Dr. Lang graduated from the Des Moines University College of Osteopathic Medicine in 1981. He works in Melbourne, FL and specializes in General Practice and Internal Medicine - Geriatrics. Dr. Lang is affiliated with Wuesthoff Medical Center Melbourne.
Central Ohio Pathology Associate 793 W State St, Columbus, OH 43222 6142341300 (phone), 6142342931 (fax)
Education:
Medical School University of South Dakota Sanford School of Medicine Graduated: 1989
Languages:
English
Description:
Dr. Lang graduated from the University of South Dakota Sanford School of Medicine in 1989. He works in Columbus, OH and specializes in Anatomic Pathology & Clinical Pathology. Dr. Lang is affiliated with Mount Carmel East Hospital, Mount Carmel St Anns Hospital and Mount Carmel West Hospital.
Northwestern Mutual New York, NY Sep 2012 to Jan 2013 Financial Representative InternAssociated Students of Washington State University
Sep 2010 to May 2011 SenatorCitibank Dalian, CN May 2010 to Aug 2010 Sales Assistant InternHong Kong GoodWin Investment Co., LTD Dalian, CN Jul 2007 to Jul 2008 Vice Development ManagerBusiness School
Sep 2006 to Jul 2007 Vice President, Student AssociationWashington State University Pullman, WA 2000 to 2000
Education:
New York University New York, NY May 2013 Master of Arts in EconomicsWashington State University Pullman, WA May 2011 Bachelor of Science in Economics
License Records
Eric A Lang
License #:
51006 - Active
Category:
EMS Licensing
Issued Date:
Apr 7, 2016
Expiration Date:
Jun 30, 2018
Type:
EMT-Paramedic
Eric A Lang
License #:
57563 - Active
Category:
EMS Licensing
Issued Date:
Mar 4, 2016
Expiration Date:
Jun 30, 2018
Type:
EMT-Paramedic with Critical Care Endorsement
Us Patents
Intrathecal Or Epidural Administration Of 3-[(1S,2S)-3-(Dimethylamino)-1-Ethyl-2-Methylpropyl]Phenol
Petra BLOMS-FUNKE - Wuerselen, DE Derek John SAUNDERS - Aachen, DE Eric LANG - Plainsboro NJ, US
Assignee:
Gruenenthal GmbH - Aachen
International Classification:
A61K 31/137
US Classification:
514654
Abstract:
The present invention relates to a method of providing pain management in a subject wherein the administration of the composition does not result in any non-central nervous system mediated systemic effect in the subject. In particular, the present invention relates to a method of administering 3-[(1S,2S)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]-phenol in a space that is void of thrombocytes.
News
French president arrives in Egypt, business deals in sights
Hollande told reporters he brought up Regeni's case with el-Sissi as well as that of French citizen Eric Lang who was beaten to death, allegedly by other detainees, while in police custody in September 2013.